Main Products
Medigator AI-powered and evidence-based guidance for immunotherapy • Proactively analyze medical records to identify appropriate candidates for immunotherapy • Recommends targeted immunotherapy plans for early, mid and late-stage cancer patients • Predict individual risk of immune-related adverse events (irAEs) and manage medications • Tracks and predicts progression, prognosis and the efficacy of immunotherapy • Organizing evidence-based clinical guidance for immunotherapy • Better shared decision making with more information
Business Interests
Market expansion, Collaborative R&D
Contact Info
Jeremiah Scholl
Chief of Product
+1-415-18-0633
waynewei@formosapharma.com